(1->4)-beta-D-glucan multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IRF2BP2 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2BP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Irf2bp2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of IRF2BP2 mRNA CTD PMID:22206623 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of IRF2BP2 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO IRF2BP2 (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Irf2bp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of IRF2BP2 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IRF2BP2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Irf2bp2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of IRF2BP2 mRNA CTD PMID:28922406 2-hydroxypropanoic acid increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of IRF2BP2 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO IRF2BP2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of IRF2BP2 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine decreases expression ISO Irf2bp2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of IRF2BP2 mRNA CTD PMID:26251327 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Oxazolone results in increased expression of IRF2BP2 mRNA CTD PMID:23999411 aflatoxin B1 increases methylation ISO IRF2BP2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of IRF2BP2 gene CTD PMID:28458013 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IRF2BP2 mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO IRF2BP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of IRF2BP2 gene CTD PMID:27153756 antirheumatic drug increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of IRF2BP2 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO IRF2BP2 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of IRF2BP2 mRNA CTD PMID:33212167 atrazine increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Atrazine results in increased expression of IRF2BP2 mRNA CTD PMID:22378314 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 benzo[a]pyrene diol epoxide I decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression ISO Irf2bp2 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of IRF2BP2 mRNA CTD PMID:26377693 bisphenol A affects expression ISO IRF2BP2 (Homo sapiens) 6480464 bisphenol A affects the expression of IRF2BP2 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IRF2BP2 mRNA CTD PMID:32145629 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of IRF2BP2 mRNA CTD PMID:32479839 butan-1-ol multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IRF2BP2 mRNA CTD PMID:29432896 butanal decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of IRF2BP2 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of IRF2BP2 mRNA CTD PMID:33453195 caffeine decreases phosphorylation ISO IRF2BP2 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of IRF2BP2 protein CTD PMID:35688186 carbamazepine affects expression ISO IRF2BP2 (Homo sapiens) 6480464 Carbamazepine affects the expression of IRF2BP2 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Irf2bp2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 casticin decreases expression ISO Irf2bp2 (Mus musculus) 6480464 casticin results in decreased expression of IRF2BP2 mRNA CTD PMID:28444820 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 chlorpyrifos increases expression ISO Irf2bp2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of IRF2BP2 mRNA CTD PMID:37019170 coumestrol decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Coumestrol results in decreased expression of IRF2BP2 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of IRF2BP2 mRNA CTD PMID:19167446 deoxynivalenol increases expression ISO IRF2BP2 (Homo sapiens) 6480464 deoxynivalenol results in increased expression of IRF2BP2 mRNA CTD PMID:31863870 dorsomorphin multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of IRF2BP2 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IRF2BP2 protein CTD PMID:23301498 epoxiconazole increases expression ISO Irf2bp2 (Mus musculus) 6480464 epoxiconazole results in increased expression of IRF2BP2 mRNA CTD PMID:35436446 fipronil increases expression EXP 6480464 fipronil results in increased expression of IRF2BP2 mRNA CTD PMID:34044035 fluoranthene multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2BP2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2BP2 mRNA CTD PMID:22206623 folic acid decreases expression ISO Irf2bp2 (Mus musculus) 6480464 Folic Acid results in decreased expression of IRF2BP2 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of IRF2BP2 mRNA CTD PMID:20655997 FR900359 affects phosphorylation ISO IRF2BP2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of IRF2BP2 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of IRF2BP2 mRNA CTD PMID:33387578 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 hydrogen cyanide increases expression ISO Irf2bp2 (Mus musculus) 6480464 Hydrogen Cyanide results in increased expression of IRF2BP2 mRNA CTD PMID:33914522 hydrogen peroxide multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 N-(oxo-5 more ... CTD PMID:31494107 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 Indeno[1,2,3-cd]pyrene decreases expression ISO Irf2bp2 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 inulin multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IRF2BP2 mRNA CTD PMID:36331819 ivermectin decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of IRF2BP2 protein CTD PMID:32959892 lead diacetate increases expression ISO Irf2bp2 (Mus musculus) 6480464 lead acetate results in increased expression of IRF2BP2 mRNA CTD PMID:20542052 leflunomide increases expression ISO IRF2BP2 (Homo sapiens) 6480464 leflunomide results in increased expression of IRF2BP2 mRNA CTD PMID:28988120 menadione affects expression ISO IRF2BP2 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of IRF2BP2 mRNA CTD PMID:20044591 mercury dichloride decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of IRF2BP2 mRNA CTD PMID:27188386 metformin decreases expression EXP 6480464 Metformin results in decreased expression of IRF2BP2 mRNA CTD PMID:31324951 methyl methanesulfonate decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of IRF2BP2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO IRF2BP2 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of IRF2BP2 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRF2BP2 mRNA CTD PMID:27188386 monosodium L-glutamate decreases expression ISO Irf2bp2 (Mus musculus) 6480464 Sodium Glutamate results in decreased expression of IRF2BP2 mRNA CTD PMID:22078008 motexafin gadolinium increases expression ISO IRF2BP2 (Homo sapiens) 6480464 motexafin gadolinium results in increased expression of IRF2BP2 mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IRF2BP2 mRNA CTD PMID:16357179 N(4)-hydroxycytidine decreases expression ISO Irf2bp2 (Mus musculus) 6480464 N(4)-hydroxycytidine results in decreased expression of IRF2BP2 mRNA CTD PMID:37748715 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of IRF2BP2 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO IRF2BP2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of IRF2BP2 mRNA CTD PMID:24810058 niclosamide increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Niclosamide results in increased expression of IRF2BP2 mRNA CTD PMID:36318118 ozone multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IRF2BP2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IRF2BP2 mRNA CTD PMID:34911549 paracetamol decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of IRF2BP2 mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IRF2BP2 mRNA CTD PMID:33387578 paracetamol affects expression ISO Irf2bp2 (Mus musculus) 6480464 Acetaminophen affects the expression of IRF2BP2 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IRF2BP2 mRNA more ... CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of IRF2BP2 gene CTD PMID:33148267 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of IRF2BP2 mRNA CTD PMID:31324951 phenobarbital affects expression ISO Irf2bp2 (Mus musculus) 6480464 Phenobarbital affects the expression of IRF2BP2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of IRF2BP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRF2BP2 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IRF2BP2 mRNA CTD PMID:19710929 potassium cyanide increases expression ISO Irf2bp2 (Mus musculus) 6480464 Potassium Cyanide results in increased expression of IRF2BP2 mRNA CTD PMID:33914522 propiconazole decreases expression ISO Irf2bp2 (Mus musculus) 6480464 propiconazole results in decreased expression of IRF2BP2 mRNA CTD PMID:21278054 quercitrin increases expression ISO IRF2BP2 (Homo sapiens) 6480464 quercitrin results in increased expression of IRF2BP2 mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of IRF2BP2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of IRF2BP2 mRNA CTD PMID:19167446 resveratrol multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of IRF2BP2 mRNA] CTD PMID:31298478 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of IRF2BP2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of IRF2BP2 mRNA CTD PMID:25895662 sodium arsenate decreases expression ISO Irf2bp2 (Mus musculus) 6480464 sodium arsenate results in decreased expression of IRF2BP2 mRNA CTD PMID:21795629 sunitinib increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Sunitinib results in increased expression of IRF2BP2 mRNA CTD PMID:31533062 tamoxifen increases expression ISO Irf2bp2 (Mus musculus) 6480464 Tamoxifen results in increased expression of IRF2BP2 mRNA CTD PMID:25123088 tetrachloromethane multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of IRF2BP2 mRNA] CTD PMID:18038451 tetrachloromethane increases expression ISO Irf2bp2 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of IRF2BP2 mRNA CTD PMID:31919559 tetraphene decreases expression ISO Irf2bp2 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of IRF2BP2 mRNA CTD PMID:26377693 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA CTD PMID:33854195 thimerosal decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 Thimerosal results in decreased expression of IRF2BP2 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IRF2BP2 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO Irf2bp2 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of IRF2BP2 mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO Irf2bp2 (Mus musculus) 6480464 titanium dioxide results in increased expression of IRF2BP2 mRNA CTD PMID:31298478 titanium dioxide decreases expression ISO Irf2bp2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of IRF2BP2 mRNA CTD PMID:27760801 Tributyltin oxide decreases phosphorylation ISO Irf2bp2 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased phosphorylation of IRF2BP2 protein CTD PMID:22174045 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of IRF2BP2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO IRF2BP2 (Homo sapiens) 6480464 trichostatin A results in increased expression of IRF2BP2 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A affects expression ISO IRF2BP2 (Homo sapiens) 6480464 trichostatin A affects the expression of IRF2BP2 mRNA CTD PMID:28542535 trichostatin A multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRF2BP2 mRNA CTD PMID:27188386 troglitazone decreases expression ISO Irf2bp2 (Mus musculus) 6480464 troglitazone results in decreased expression of IRF2BP2 mRNA CTD PMID:28973697 valproic acid increases methylation ISO IRF2BP2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of IRF2BP2 gene CTD PMID:29154799 valproic acid affects expression ISO IRF2BP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of IRF2BP2 mRNA CTD PMID:25979313 valproic acid increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of IRF2BP2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IRF2BP2 mRNA CTD PMID:27188386 vorinostat decreases expression ISO IRF2BP2 (Homo sapiens) 6480464 vorinostat results in decreased expression of IRF2BP2 mRNA CTD PMID:27188386 zinc acetate multiple interactions ISO IRF2BP2 (Homo sapiens) 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of IRF2BP2 mRNA CTD PMID:16357179 zinc acetate increases expression ISO IRF2BP2 (Homo sapiens) 6480464 Zinc Acetate results in increased expression of IRF2BP2 mRNA CTD PMID:16357179